Cleerly's $106M Boost: AI-Powered Heart Health Revolution

Matilda
Cleerly's $106M Boost: AI-Powered Heart Health Revolution
Heart disease remains a leading global health concern, often striking without warning. Cleerly, a pioneering cardiovascular imaging startup, is on a mission to change this. By leveraging advanced AI, the company aims to identify early-stage coronary artery disease through CT scans, much like mammograms and colonoscopies detect other cancers. A Visionary Approach Founded by renowned cardiologist Dr. James Min, Cleerly emerged from a clinical program at New York-Presbyterian Hospital/Weill Cornell Medicine. Dr. Min's vision is clear: "The majority of people who will die of heart disease and heart attacks will never have any symptoms. At some point, we need to start screening the world for heart disease." A Promising Future Cleerly is currently conducting a large-scale clinical trial to validate its AI-powered screening method's accuracy in detecting heart conditions in asymptomatic individuals. If successful, this breakthrough could revolutionize preventive healthcare, ena…